Seroepidemiology of pertussis in China: A population-based, cross-sectional study

Zhujiazi Zhang1, Jingbin Pan1, Meng Chen1

  • 1Department of Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China.

Vaccine
|March 1, 2021
PubMed

Insights

Pertussis vaccination boosts antibodies, but immunity wanes by school age, increasing infection risk. A preschool booster may enhance protection against pertussis.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Pertussis incidence increased in China (2013-2017) despite high vaccination rates.
  • The Expanded Programme on Immunization (1978) initially reduced pertussis, but recent trends show resurgence.

Purpose of the Study:

  • To evaluate the immune response to pertussis in vaccinated children in China.
  • To assess antibody levels and infection rates in different age groups.

Main Methods:

  • Recruited 2,144 healthy subjects for serum IgG antibody testing against pertussis toxin (anti-PT IgG) via ELISA.
  • Calculated geometric mean concentration (GMC), seropositivity, and recent infection rates.
  • Stratified analysis by vaccination schedule, age intervals, and vaccine type (DTaP vs. DTaP-IPV/PRP~T).

Main Results:

  • Anti-PT IgG GMC in 0-6-year-olds was 5.99 IU/ml, declining after primary and booster doses, reaching a nadir at 6 years.
  • GMCs were higher with DTaP-IPV/PRP~T compared to DTaP vaccines.
  • In individuals >6 years, seropositivity increased from age 6, peaking at 9 years (10.3%).

Conclusions:

  • Pertussis vaccination elicits anti-PT IgG, but immunity wanes over time.
  • Sero-estimated pertussis infection rates rise from school age, peaking around 9 years.
  • Results suggest a preschool booster dose of pertussis vaccine could be beneficial.
Abstract